Buhali, Baby Girl .
HRN: 21-46-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
AMPICILLIN 500MG (VIAL)
06/10/2022
06/16/2022
IV
134
Q12hrs
PSNB (Non Institutionalized Delivery)
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes